Aprameya Engineering Ltd
Incorporated in September 2003, Aprameya Engineering Limited specializes in installing and maintaining Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care centers.[1]
- Market Cap ₹ 450 Cr.
- Current Price ₹ 236
- High / Low ₹ 360 / 93.0
- Stock P/E 18.3
- Book Value ₹ 37.3
- Dividend Yield 0.00 %
- ROCE 31.1 %
- ROE 36.8 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 90.1% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 30.2%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 320 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 12 | 26 | 35 | 78 | 65 | 136 | 169 | |
| 11 | 24 | 25 | 69 | 59 | 111 | 132 | |
| Operating Profit | 2 | 2 | 10 | 9 | 6 | 24 | 37 |
| OPM % | 13% | 9% | 29% | 12% | 10% | 18% | 22% |
| 0 | 0 | 0 | 0 | 0 | 1 | 0 | |
| Interest | 1 | 1 | 0 | 2 | 2 | 3 | 4 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 2 | 10 | 7 | 5 | 22 | 33 |
| Tax % | 8% | 44% | 25% | 28% | 24% | 26% | |
| 1 | 1 | 7 | 5 | 3 | 16 | 25 | |
| EPS in Rs | 10.66 | 3.84 | 2.49 | 8.47 | 12.92 | ||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 62% |
| 3 Years: | 57% |
| TTM: | 108% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 90% |
| 3 Years: | 29% |
| TTM: | 362% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 135% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 35% |
| 3 Years: | 30% |
| Last Year: | 37% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 7 | 14 | 14 | 19 | 19 |
| Reserves | 0 | 0 | 7 | 6 | 9 | 45 | 52 |
| 4 | 1 | 14 | 29 | 42 | 30 | 37 | |
| 6 | 5 | 20 | 13 | 10 | 49 | 26 | |
| Total Liabilities | 14 | 11 | 49 | 62 | 76 | 144 | 135 |
| 1 | 1 | 2 | 1 | 1 | 1 | 1 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 13 | 10 | 47 | 60 | 74 | 143 | 133 | |
| Total Assets | 14 | 11 | 49 | 62 | 76 | 144 | 135 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 0 | 4 | 10 | -13 | -10 | -11 | |
| -1 | 0 | -0 | -2 | -1 | -0 | |
| 1 | -4 | -8 | 13 | 11 | 11 | |
| Net Cash Flow | 0 | -0 | 2 | -2 | 0 | -0 |
| Free Cash Flow | -0 | 4 | 10 | -14 | -11 | -11 |
| CFO/OP | 22% | 173% | 149% | -115% | -133% | -28% |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 182 | 58 | 278 | 195 | 325 | 320 |
| Inventory Days | 245 | 122 | 455 | 376 | 74 | |
| Days Payable | 269 | 147 | 1,100 | 415 | 146 | |
| Cash Conversion Cycle | 159 | 33 | -367 | 157 | 253 | 320 |
| Working Capital Days | 40 | 36 | 200 | 116 | 153 | 166 |
| ROCE % | 35% | 59% | 25% | 12% | 31% |
Insights
In beta| Mar 2024 | Mar 2025 | |
|---|---|---|
| Number of Employees Numbers |
|
|
| Number of States Present Numbers |
||
| Revenue Mix - Medical Equipment Solutions % |
||
| Revenue Mix - Turnkey Projects % |
||
| Number of Critical Care Beds Installed Numbers |
||
| Number of Dialysis Centers Delivered (Rajasthan) Numbers |
||
| Number of Global OEM Partnerships Numbers |
||
| Order Book Rs Mn |
||
Documents
Announcements
-
Agreements
1 April 2026 - Aprameya provided INR 4.00 Crore corporate guarantee to PNB for subsidiary Aprameya Medtech (70% owned).
-
Trading Window
27 March 2026 - Trading window closed Apr 1, 2026 until 48 hours after FY2025-26 results declaration (period ended Mar 31, 2026).
-
Agreements
17 March 2026 - Aprameya to provide corporate guarantee of INR 4.00 Crore to PNB for Aprameya Medtech; agreement dated 16 Mar 2026.
-
Analysts/Institutional Investor Meet/Con. Call Updates
1 December 2025 - Participating virtually in SAMRUDHI 2.0 SME Conclave on 3 Dec 2025, 3:00 PM.
-
Analysts/Institutional Investor Meet/Con. Call Updates
27 November 2025 - Investor meeting on Dec 2, 2025 at Emerging Ideas Conference 2025; presentation public.
Annual reports
Concalls
-
Nov 2025TranscriptAI SummaryPPT
-
May 2025Transcript PPT REC
Business Segments
A) Healthcare Infrastructure Projects[1][2]
The company offers turnkey solutions for developing healthcare facilities, covering everything from design to execution of ICUs, NICUs, PICUs, Modular Operation Theatres (MOTs), Dialysis Centers, and Prefabricated Wards. The scope also includes integration of MEP systems, fire safety, structural design, and hospital interiors. These projects are tailored for public healthcare institutions, focused on customized infrastructure delivery.